Cargando…

Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic and contagious coronavirus that caused a global pandemic with 5.2 million fatalities to date. Questions concerning serologic features of long-term immunity, especially dominant epitopes mediating durable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Liu, Jiaojiao, Lu, Renfei, Zhang, Yuchao, Du, Meng, Xing, Man, Wu, Zhenchuan, Kong, Xiangyin, Zhu, Yufei, Zhou, Xianchao, Hu, Landian, Zhang, Chiyu, Zhou, Dongming, Jin, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779849/ https://www.ncbi.nlm.nih.gov/pubmed/35074422 http://dx.doi.org/10.1016/j.jaci.2022.01.005

Ejemplares similares

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

A Review of Viral Shedding in Resolved and Convalescent COVID-19 Patients
por: Karia, Rutu, et al.
Publicado: (2020)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
por: Hou, Hongyan, et al.
Publicado: (2021)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report
por: Fox, Henrik, et al.
Publicado: (2022)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Is Eye Immune-Privileged to COVID-19 Infection?
por: Kozak, Igor
Publicado: (2021)

Herd immunity: challenges and the way forward in Korea
por: Oh, Jiyoung, et al.
Publicado: (2021)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
por: Bhattacharjee, Sukrita, et al.
Publicado: (2020)

COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
por: Khalife, Jade, et al.
Publicado: (2021)

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
por: Meyts, Isabelle, et al.
Publicado: (2021)

Immune health grades: Finding resilience in the COVID-19 pandemic and beyond
por: Marconi, Vincent C., et al.
Publicado: (2022)

Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
por: Pham, Amelie, et al.
Publicado: (2021)

Preexisting comorbidities shape the immune response associated with severe COVID-19
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
por: Cimolai, Nevio
Publicado: (2020)

COVID-19 Vaccine Superstations as a Model to Rapidly Achieve Herd Immunity
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Phenotypic analysis of the pediatric immune response to SARS‐CoV‐2 by flow cytometry
por: Sibbertsen, Freya, et al.
Publicado: (2022)

Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
por: Hagin, David, et al.
Publicado: (2021)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
por: Lavin, Michelle, et al.
Publicado: (2021)

SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
por: Björkander, Sophia, et al.
Publicado: (2022)

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization
por: Meyer-Szary, Jaroslaw, et al.
Publicado: (2022)

Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
por: Kumar, Deepak, et al.
Publicado: (2022)

Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19
por: Payus, Alvin Oliver, et al.
Publicado: (2021)

Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response
por: Ramasamy, Karthik, et al.
Publicado: (2022)

Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign
por: BECHINI, ANGELA, et al.
Publicado: (2023)

Cross‐reactive cellular, but not humoral, immunity is detected between OC43 and SARS‐CoV‐2 NPs in people not infected with SARS‐CoV‐2: Possible role of cT(FH) cells
por: García‐Jiménez, Álvaro Fernando, et al.
Publicado: (2022)

Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID‐19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
por: Marasco, Vincenzo, et al.
Publicado: (2021)

Clinical Features of COVID-19 Patients in Xiaogan City
por: Feng, Gong, et al.
Publicado: (2020)

Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach
por: Mirandola, Laura, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals the suppressive effect of PPP1R15A inhibitor Sephin1 in antitumor immunity
por: Wang, Rongjing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o6vqvkok1q6gt09kq28fq33ld1